NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Big Find: CEO Linda Powers has cloned herself with a high powered $Big hire in 2014 for Cognate Biosciences:Shari Lisa Piré Chief Legal Officer, with impressive high powered legal experience: a year@ Willkie Farr NYC; 8 yrs at Les Goldman's Skadden, Arps Paris, 1994 JD Magna Cum Laude New York Law,2 yrs as Editor, New York Law School Law Review.
See https://www.linkedin.com/in/sharipire?authType=name&authToken=Q6Gw&trk=prof-sb-browse_map-name

CORPORATE TRANSACTIONS: Structure, negotiate, lead and document every nature of corporate transaction, including M&A, financings, partnerships, collaborations, research studies, clinical trials, intellectual property-related, manufacturing and other commercial transactions across the U.S., Europe, Asia and Latin America.

CORPORATE GOVERNANCE & OPS: Work closely with the board and senior management team on implementing business initiatives, day-to-day operations, and governance.

DEVELOPMENT & STRATEGY: Influence and advise on corporate strategy, including risks and benefits associated with transaction structuring and implementation. Align transactions with broader business objectives.

LEGAL & REGULATORY COMPLIANCE: Advise on and ensure compliance of both public and privately held companies with applicable laws and regulations, including securities, and antitrust and competition laws, FDA and international counterparts, cGMP, anti-corruption and anti-bribery, and corporate law. Manage filings and public disclosures with the SEC and other regulatory authorities.

AND this says it all for Shari's LARGE role@"Cognate PLUS":

Ms. Piré is fully engaged in the resolution of a wide range of legal and general management issues. Leading all of the legal and corporate affairs of Cognate and its affiliates, Ms. Piré, develops, directs and advises the Board and the CEO, COO, CFO, and other executives on all legal and strategic matters. More specifically, Ms. Piré implements and manages all legal aspects of Cognate’s business, including its growth strategy, acquisitions, manufacturing and development activities. She is further responsible for addressing regulatory matters (including FDA and cGMP) and for the strategy, maintenance and prosecution of the company’s global patent portfolio and all litigation involving the company. Ms. Piré also provides a wide variety of legal services to Cognate’s partners and affiliates, including entities engaged in the development of immunotherapies and related products and services for the regenerative medicine industry.

One year later in 2015, CEO Linda Powers follows up by hiring a CFO for Cognate Biosciences,Phillipe Pire who happens to be Shari Pire's husband whom she likely met in NYC in the late '90's. https://www.linkedin.com/in/philippe-pire-2b700833?authType=name&authToken=msNh&trk=prof-sb-browse_map-name

One does NOT hire a CFO for NWBO (a strong rebuke I offered years ago (NO ROI when other more pressing funding for trials. Well here is the formal repudiation for all those in your face non stop naysayers ie Austin; Steppenwolf, etc). Since Cognate Bioservices is worldwide and is the vaccine mfr.that's where a CFO is needed at where the action takes place.

So clearly all of the above is SUB ROSA and no one heretofore has pointed this out.

With these two key hires, CEO Linda Powers can focus on the larger issues while still having oversight,comfort and guidance via experienced hands.